Sign Up for a Free Account

This is an image preview.
Start a Free Account
to view the full image.

  • Nearly 3,000 illustrations, including video clips of neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of neurology in 1,200 comprehensive articles.

  • Listen to MedLink on the go with Audio versions of each article.

Evidence-based medicine measures from trials of mitoxantrone, glatiramer acetate, or natalizumab in relapsing-remitting multiple sclerosis

Evidence-based medicine measures calculated from the published trials of mitoxantrone, glatiramer acetate, or natalizumab in relapsing-remitting multiple sclerosis. (Contributed by Dr. Luca Durelli.)

Related Media